arrow_back Back to App

Equal Access to COVID-19 Treatments: Prohibiting Racial Discrimination

This act aims to ensure that access to COVID-19 treatments, such as monoclonal antibody therapies, is not based on race or ethnicity. This means every citizen should have an equal chance to receive necessary treatment, regardless of these factors. Additionally, hospitals and medical facilities that implement such restrictions will lose federal funding.
Key points
Prohibits racial or ethnic discrimination in access to COVID-19 treatments.
Individuals responsible for denying treatment based on race may face personal liability in case of patient death.
Hospitals and healthcare providers that discriminate will lose federal funding.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6625
Sponsor: Rep. Davis, Rodney [R-IL-13]
Process start date: 2022-02-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Equal Access to Therapeutics Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6625.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-02-07.

What are the main provisions?

Key points include:

  • Prohibits racial or ethnic discrimination in access to COVID-19 treatments.
  • Individuals responsible for denying treatment based on race may face personal liability in case of patient death.
  • Hospitals and healthcare providers that discriminate will lose federal funding.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Rodney [R-IL-13].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health